PhaseII stady of gefitinib and in patients with relapsed advanced non-small cell lung cancer
Not Applicable
- Conditions
- relapsed advanced non-small cell lung cartinoma
- Registration Number
- JPRN-C000000142
- Lead Sponsor
- Department of Medical Oncology Kinki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Uncontrolled infection, cardiac disease, hepatic disease, and so on (2)Evidence of interstitial lung disease in chest x-p (3)Active brain metastases (4)Other active malignancy (5)History of bone marrow transplantation (6)History of peripheral blood stem cell transplantation (7)Allergy to any drugs (8)Pregnant or nursing women (9)Patients don't have will of contraception (10)Uncontrolled diabetes (11)Other concurrent serious medical condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method